Publications by authors named "Kei Oguchi"

Claim this Profile
T
TAS2940, a novel brain-penetrable pan-ERBB inhibitor, for tumors with HER2 and EGFR aberrations.
Kei Oguchi, Hikari Araki, Shingo Tsuji, Masayuki Nakamura, Akihiro Miura

Cancer Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models.
Hiroki Irie, Kimihiro Ito, Yayoi Fujioka, Kei Oguchi, Akio Fujioka

Mol Cancer Ther· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.
Kazuki Sakamoto, Tatsushi Yokogawa, Hiroyuki Ueno, Kei Oguchi, Hiromi Kazuno

Int J Oncol· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.
Nozomu Tanaka, Kazuki Sakamoto, Hiroyuki Okabe, Akio Fujioka, Keisuke Yamamura, Kei Oguchi

Oncol Rep· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nuclear localization of profilin III-ArpM1 complex in mouse spermiogenesis.
Yuki Hara, Kazuo Yamagata, Kei Oguchi, Tadashi Baba

FEBS Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis